Agalsidase Beta Long-Term Treatment Outcome for Fabry Disease Patients With IVS4 Mutation in Taiwan

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

September 13, 2023

Primary Completion Date

September 10, 2026

Study Completion Date

September 10, 2026

Conditions

Fabry Disease

Trial Locations (5)

Investigational Site Number : 1580001, Taipei

Investigational Site Number : 1580003, Taipei

Investigational Site Number : 1580002, Taipei

Investigational Site Number : 1580005, Tainan City

Investigational Site Number : 1580004, Taichung